- Who We Are
Profile and Organization
- Our Vision & Strategy
- Our Contributions
- Our Values
- Diversity, Equity & Inclusion at Bayer
- Team Bayer
- Bayer Worldwide
- Corporate Compliance
- Contact Us
Names, Facts, Figures about Bayer
Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time.
A growing and aging world population requires an adequate supply of food and improved medical care. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time. With life expectancy continuing to rise, we improve quality of life for a growing population by focusing our research and development activities on preventing, alleviating and treating diseases. We are also making an important contribution to providing a reliable supply of high-quality food, feed and plant-based raw materials.
Our goal is to create value for our customers, stockholders and employees, while also strengthening the company’s earning power. We are committed to operating sustainably and addressing our social and ethical responsibilities. Employees with a passion for innovation enjoy excellent development opportunities at Bayer. All this goes to make up our purpose:
The Bayer Group is managed as a life science company with three divisions – Pharmaceuticals, Consumer Health and Crop Science, which are also our reporting segments. The Enabling Functions support the operational business. As of December 31, 2022, the Bayer Group comprised 354
consolidated companies in 83 countries.
Structure of the Bayer Group
The Pharmaceuticals division focuses on prescription products, especially for cardiology and women’s healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The division also comprises the radiology business, which markets diagnostic imaging equipment together with the necessary contrast agents.
The Consumer Health division markets mainly nonprescription (OTC = over-the-counter) products in the dermatology, nutritional supplement, analgesic, digestive health, cold, allergy, sinus and flu categories.
The Crop Science division is a world-leading agriculture enterprise with businesses in seeds, crop protection and nonagricultural pest control. The Crop Protection / Seeds operating unit markets a broad portfolio of high-value seeds and innovative pest management solutions, while at the same time providing extensive customer service for sustainable agriculture.
The Enabling Functions operate as Group-wide competence centers in which business support services are bundled.
With our products, we are contributing to finding solutions to some of the major challenges of our time. The growing and increasingly aging world population requires improved medical care and an adequate supply of food. Bayer is improving people’s quality of life by preventing, alleviating and curing diseases. And we are helping to provide a reliable supply of high-quality food, feed and plant-based raw materials.
Bayer’s extensive product portfolio contains numerous globally renowned brands.
- in the Pharmaceuticals field: Adalat™, Adempas™, Aspirin™ Cardio, Betaferon™/Betaseron™, CT Fluid Delivery, Eylea™, Gadovist™ product family, Kogenate™/Kovaltry™/Jivi™, Mirena™/Kyleena™/Jaydess™, Nexavar™, Nubeqa™, Stivarga™, Ultravist™, YAZ™/Yasmin™/Yasminelle™, Xarelto™
- in the Consumer Health field: Aleve™, Alka-Seltzer™, Afrin™, Aspirin™, Bepanthen™, Berocca™, Canesten™, Claritin™, Elevit™, Iberogast™, One A Day™, Redoxon™, Rennie™, MiraLAX™, Supradyn™
- the key brands in the agriculture field are: Confidor™/ Gaucho™/ Nativo™-Produktfamilie und die Prosaro™-Produktfamilie
The Bayer Group comprised 354 consolidated companies in 83 countries. Global headquarters are in Leverkusen, Germany.
** fully consolidated subsidiaries (As of December 31, 2022)
On December 31, 2022, we employed 101,369 people (2021: 99,637) worldwide. In Germany, we had 22,569 (2021: 23,116) employees, representing 22.3% of the total Group workforce (2021: 23.2%).
Employees by Region and Gender in 2022
- included in nearly all the major share indices
- traded on all German stock exchanges
- dividend per share €2.4 (2022)
Bayer Group Key Data
|€ million||€ million||%|
|EBIT before special items2||7,295||9,257||26.90|
|EBITDA before special items2||11,179||13,513||20.88|
|EBITDA margin before special items (in %)4||25.4||26.6||4.72|
|Income before income taxes||2,046||4,670||128.25|
|Earnings per share (€)5||1.02||4.22||313.73|
|Core earnings per share (€)6||6.51||7.94||21.97|
|Net financial debt||33,137||31,809||-4.01|
|Capital expenditures as per segment table||3,004||3,639||21.14|
|Research and development expenses||5,412||6,572||21.43|
|Dividend per Bayer AG share (€)||2.00||2.4||20.00|
1-6 for definition see footnotes to alternative performance measures Bayer Group (as of Dec. 31, 2022)